AstraZeneca Total Non-Operating Income/Expense 2010-2024 | AZN
AstraZeneca total non-operating income/expense for the twelve months ending December 31, 2024 was $-1.312B, a 1.39% increase year-over-year.
- AstraZeneca annual total non-operating income/expense for 2024 was $-1.312B, a 1.39% increase from 2023.
- AstraZeneca annual total non-operating income/expense for 2023 was $-1.294B, a 3.03% increase from 2022.
- AstraZeneca annual total non-operating income/expense for 2022 was $-1.256B, a 4.92% decline from 2021.